# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-267061
Filing Date
2025-11-05
Accepted
2025-11-05 16:31:01
Documents
76
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | adpt-20250930.htm iXBRL | 10-Q | 3132243
2 | EX-31.1 | adpt-ex31_1.htm | EX-31.1 | 19245
3 | EX-31.2 | adpt-ex31_2.htm | EX-31.2 | 19239
4 | EX-32.1 | adpt-ex32_1.htm | EX-32.1 | 11954
5 | EX-32.2 | adpt-ex32_2.htm | EX-32.2 | 13347
| Complete submission text file | 0001193125-25-267061.txt |  | 11452830

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | adpt-20250930.xsd | EX-101.SCH | 1179788
79 | EXTRACTED XBRL INSTANCE DOCUMENT | adpt-20250930_htm.xml | XML | 2420105

Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 251454552
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)